H2020 and other european grant programs for medical life sciences organisations, is the presentation made by Corjan VISSER, Manager Life Sciences & Health at PNO Consultants.
How to write a winning H2020 Proposal SME Instrument Phase 2 - UpdatedH2020 Manuals
We have updated your step by step tools to win the Horizon 2020 SME Instrument Phase 2 grant. Some quick quesstions were added so you can simplify the beginning of your proposal preparation.Find out more at http://www.h2020manuals.eu/ or http://store.h2020manuals.eu/.
You can find our previous slideshare at: https://www.slideshare.net/H2020Manuals/how-to-write-a-winning-h2020-proposal-sme-instrument-phase-2-57179980
How to write a winning H2020 Proposal SME Instrument Phase 2 - UpdatedH2020 Manuals
We have updated your step by step tools to win the Horizon 2020 SME Instrument Phase 2 grant. Some quick quesstions were added so you can simplify the beginning of your proposal preparation.Find out more at http://www.h2020manuals.eu/ or http://store.h2020manuals.eu/.
You can find our previous slideshare at: https://www.slideshare.net/H2020Manuals/how-to-write-a-winning-h2020-proposal-sme-instrument-phase-2-57179980
Horizon 2020: Challenges and opportunities for SpainVLC/CAMPUS
Slides from Carlos Martínez Riera presenting how to develop regional innovation ecosystems through RIS3, Horizon 2020 and European partnerships. Those slides are part of the conference "Position and strategies of the universities in the new European scenario of R&D and innovation: Horizon 2020, KICs and RIS3" held at Universitat Politècnica de València last December 18th 2013 as part of the VLC/CAMPUS activities
The webinar provided background information on support available for both UK and European organisations in how to apply for funding and search for partners. KTN hosted this event on behalf of Innovate UK and it was delivered by Stafford Lloyd, National Contact Point ICT, Innovate UK, Viola Hay, Knowledge Transfer Manager - European Programmes, KTN, and Natalie Withenshaw, Marketing Manager, KTN. A big thank you to the Speakers and Organisers.
This webinar gave an overview of Horizon 2020 (H2020)* Cascade Funding opportunities, background information and support available for both UK and European organisations in how to apply for this funding and help with search for partners.
Cascade Funding, also known as Financial Support to Third Parties (FSTP), is a mechanism of the European Commission to distribute public funds in order to create new companies, increase their scalability, SMEs and / or mid-cap companies, in the adoption or development of digital innovation.
The main objective of this financing method is to simplify administrative procedures with SMEs, thus allowing some projects financed by the EU to issue, in turn, open calls to obtain more funding.
Find out more here: https://ktn-uk.co.uk/news/horizon-2020-cascade-funding-webinar-recording-and-slides-now-available/
The European R&I program H2020: "linking Research with Innovation to create ...Pasteur_Tunis
The European R&I program H2020:
"linking Research with Innovation to create Impact in Society"
Presentation done durin the H2020 infoday at Institut Pasteur de Tunis, may, 15, 2014
European innovation and business culture: What Chinese should know for slide ...InnoPraxis International
Presentation at annual TII conference (Technology Innovation International) on 7th of May 2013 in Beijin by Julia Roelofsen, partner in InnoPraxis International Ltd.
Anton Habjanič: IP policy model at the University of MariborCUBCCE Conference
As the global knowledge economy grows each year, the importance of intellectual property (IP) policy also grows for non-profit organizations such as universities. Pretty much every organization has an IP portfolio of some kind and value, whether or not the organization realizes it as such. As a result, almost every organization needs an IP policy model, even if it’s a simple one.
This presentation is intended to help the universities and other research organizations to set IP policy model to optimise the benefits from the intellectual assets created by their staff and students. The presented model, which was adopted at the University of Maribor, does not provide an IP policy that can be applied across all organizations as there is no “one size fits all” approach to IP management. But, it identifies the key features that need to be considered in order to build a strategic framework for the managing of IP, as for example the issues of ownership, protection and sharing of the economic benefits arising from the commercial exploitation of IP created by researchers in the course of their duties or activities at the university.
Technology Transfer with China: a University PerspectiveKevin De Moortel
Formal modes of technology transfer, e.g. contract research, patenting, licensing and spin-offs, are well established domestically, both in Belgium and China. When we add an international dimension to technology transfer, we see that technology transfer is present between industries. However, when we look at universities, we observe that an international technology transfer dimension is missing. This presentation sets the ground for EU-China university technology transfer.
Slides presented during #ISVwebinar n°1, 12 September 2016.
Content: The SME Instrument initiative of the EU Commission. Key elements of the programme and instructions on how to apply.
Horizon 2020: Challenges and opportunities for SpainVLC/CAMPUS
Slides from Carlos Martínez Riera presenting how to develop regional innovation ecosystems through RIS3, Horizon 2020 and European partnerships. Those slides are part of the conference "Position and strategies of the universities in the new European scenario of R&D and innovation: Horizon 2020, KICs and RIS3" held at Universitat Politècnica de València last December 18th 2013 as part of the VLC/CAMPUS activities
The webinar provided background information on support available for both UK and European organisations in how to apply for funding and search for partners. KTN hosted this event on behalf of Innovate UK and it was delivered by Stafford Lloyd, National Contact Point ICT, Innovate UK, Viola Hay, Knowledge Transfer Manager - European Programmes, KTN, and Natalie Withenshaw, Marketing Manager, KTN. A big thank you to the Speakers and Organisers.
This webinar gave an overview of Horizon 2020 (H2020)* Cascade Funding opportunities, background information and support available for both UK and European organisations in how to apply for this funding and help with search for partners.
Cascade Funding, also known as Financial Support to Third Parties (FSTP), is a mechanism of the European Commission to distribute public funds in order to create new companies, increase their scalability, SMEs and / or mid-cap companies, in the adoption or development of digital innovation.
The main objective of this financing method is to simplify administrative procedures with SMEs, thus allowing some projects financed by the EU to issue, in turn, open calls to obtain more funding.
Find out more here: https://ktn-uk.co.uk/news/horizon-2020-cascade-funding-webinar-recording-and-slides-now-available/
The European R&I program H2020: "linking Research with Innovation to create ...Pasteur_Tunis
The European R&I program H2020:
"linking Research with Innovation to create Impact in Society"
Presentation done durin the H2020 infoday at Institut Pasteur de Tunis, may, 15, 2014
European innovation and business culture: What Chinese should know for slide ...InnoPraxis International
Presentation at annual TII conference (Technology Innovation International) on 7th of May 2013 in Beijin by Julia Roelofsen, partner in InnoPraxis International Ltd.
Anton Habjanič: IP policy model at the University of MariborCUBCCE Conference
As the global knowledge economy grows each year, the importance of intellectual property (IP) policy also grows for non-profit organizations such as universities. Pretty much every organization has an IP portfolio of some kind and value, whether or not the organization realizes it as such. As a result, almost every organization needs an IP policy model, even if it’s a simple one.
This presentation is intended to help the universities and other research organizations to set IP policy model to optimise the benefits from the intellectual assets created by their staff and students. The presented model, which was adopted at the University of Maribor, does not provide an IP policy that can be applied across all organizations as there is no “one size fits all” approach to IP management. But, it identifies the key features that need to be considered in order to build a strategic framework for the managing of IP, as for example the issues of ownership, protection and sharing of the economic benefits arising from the commercial exploitation of IP created by researchers in the course of their duties or activities at the university.
Technology Transfer with China: a University PerspectiveKevin De Moortel
Formal modes of technology transfer, e.g. contract research, patenting, licensing and spin-offs, are well established domestically, both in Belgium and China. When we add an international dimension to technology transfer, we see that technology transfer is present between industries. However, when we look at universities, we observe that an international technology transfer dimension is missing. This presentation sets the ground for EU-China university technology transfer.
Slides presented during #ISVwebinar n°1, 12 September 2016.
Content: The SME Instrument initiative of the EU Commission. Key elements of the programme and instructions on how to apply.
Dr Inmaculada Higueras, Social Sciences and Humanities Thematic Lead/ Norther...IrishHumanitiesAlliance
From the IHA Impact in the Humanities event 8 June held in QUB and co-sponsored by InterTradeIreland.
Panel Two: Impact in Horizon 2020 and the EU
How is Impact conceptualised and captured at the EU level, in programmes such as Horizon 2020, and how does this affect academics, research officers and policy makers at the national level?
PluggSessions_Uncloking the Potential of DIH Collaboration_MayteCarracedo.pptxFIWARE
FIWARE iHubs focuses on matchmaking market solutions with internal challenges, accelerating the development, use and commercialization of FIWARE solutions, and nurturing a culture of digital innovation and collaboration at a local level. We understand that the driving force of the data economy is the collaboration between the many players in society, not just a single individual or company.
Each FIWARE iHub brings added value to local communities thanks to a technology that is addressing innovation needs and challenges in different sectors.
Each FIWARE iHubs is part of a worldwide community then, goes beyond regional boundaries and helps its clients to gain global positioning, get worldwide promotion and international scalability
Being part of a community, they benefit from multi-partner cooperation to reach their markets and a continuous technical enablement.
The session will bring on stage representatives from the FIWARE iHub Network sharing their experiences to grow digital innovation ecosystems in different regions around the world.
Health and Wellbeing Living Lab Symposium PresentationsVITALISEProject
The Health and Wellbeing Living Lab Symposium is dedicated to showcasing the outcomes of the VITALISE project, which focuses on harmonizing Living Lab services and procedures while recognizing Living Labs as integral Research Infrastructures. Over the past three years, a collaborative effort among Living Labs in Health has actively demonstrated the significance of Living Labs as Research Infrastructures, effectively representing the global Living Lab community. The work undertaken in VITALISE aligns with the overarching vision of Living Labs developed over the last 15 years, manifesting in project results that advance the recognition and quality of harmonized Living Labs.
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 101007990 The symposium's primary objective is to engage in collective reflection with the European Commission and relevant stakeholders and beneficiaries of Research Infrastructures. The aim is to discuss and plan the next steps toward a new era where Research Infrastructures are open and actively involve communities as powerful tools for co-research.
Presentazione Andrea Rausa di Ciaotech, Società specializzata nel supportare imprese, università e centri di ricerca nell'accesso ai finanziamenti pubblici e nell'Innovation Management, presente in Europa da oltre trent'anni
This session will cover various aspects of FIWARE, a platform designed to facilitate the development of smart solutions for a range of industries.
The session will begin with an introduction to the FIWARE Training program, which offers courses designed to help developers, entrepreneurs, and other interested parties get up to speed with FIWARE technologies.Next, attendees will learn about the FIWARE Marketplace,an online platform that provides access to FIWARE-based products and services and how to become part of it.
The session will delve into the intersection of thermodynamics and FIWARE, and how this collaboration can address climate change. Attendees will learn about the use of FIWARE in creating smart solutions for energy management, emissions reduction, and more.
Furthermore,The session will showcase the FIWARE integrated data platform for healthcare, which offers a range of tools and applications designed to improve healthcare outcomes.
Finally, the session will also explore the Smart Data Models program, which will show 6 use cases of their successful use in different industries (Health, Energy, Water, open data, etc). Attendees will learn about the benefits of using these models and how they can be integrated into various applications.
Overall, this session offers a comprehensive overview of the various aspects of FIWARE, including its marketplace, training programs, smart data models, and integrated data platforms for healthcare. The session will be beneficial for developers, entrepreneurs, and other interested parties looking to leverage FIWARE technologies to create innovative solutions for a range of industries.
In his presentation entitled: “R&D&I - Future Prospects”, Mr. Bernard Barani from EC presented the Commission’s proposals for the 2014-2020 Multiannual Financial Framework. He discussed the need for a Common Strategic Framework to increase impact and achieve simplification, while he outlined the objectives and structure of Horizon 2020.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
H2020 and other european grant programs for medical life sciences organisations
1. IMAPS; Lyon, 7-8 December 2016
Corjan J.T. Visser, PhD
H2020 and other European grant programs
for medical life sciences organisations
…and how to increase your chance of success
3. CONNECTING AMBITIONS
PNO Consultants, partner in innovation
Mission statement
To offer the best innovation consultancy &
-financing expertise in Europe
PNO today
• 30 years of working experience with
innovative organisations
• Supporting innovation - from first idea
all the way up to commercialisation
• Expertise in initiating, organising and
supporting innovation projects
• Expertise in regional, national and EU
grant schemes
• Hands-on knowledge of market sectors
• > 250 consultants, specialized sector
teams
• True European coverage: offices in 6 EU
countries and partners in most other EU
countries
IMAPS
12. CONNECTING AMBITIONS
So, before you start to write
IMAPS
Check (or build) your project:
do I really have a viable project?
-Fit with the call
-Uniqueness of the concept
-Level of innovation (going beyond state of the art)
-Strength of the consortium
-Measurable impact
-Achievable timeline
33. CONNECTING AMBITIONS
THE MOST IMPORTANT TIP:
You make or lose the interest of an evaluator
in the first page of your proposal.
After reading the first page it should be immediately clear:
•What is this project about?
•What the project wants to achieve (final result)?
•Why is it innovative? “sexy “ concept!
•Why is needed (i.e. industry/public demand)?
•Why this is important for Europe (i.e.
jobs/competitiveness/sustainability)?
•Why this is the best consortium possible (project value chain)?
IF you do not manage to make clear this in the first page,
your chances for funding are slim.
Take home messages on writing
IMAPS